Hot off the press from the RTI: Next generation APOBEC3 inhibitors: optimally designed for potency and nuclease stability pubmed.ncbi.nlm.nih.gov/40156866/?utm_… #RNA #RNATherapeutics

I am excited to announce that my laboratory UCL is now open! We are hiring so please contact us if you are interested. caswelllaboratory.com

The HPV vaccine is CRUSHING cervical cancer and at this rate will eliminate it!! An anti cancer vaccine. It's a medical miracle. HHS Secretary RFK Jr is against it

A beautiful News & Views by Leonie Unterholzner Lab highlighting our latest paper in NatureStructMolBiol, where we show that transcription stress triggers an inflammatory response through the release of IL-1α. Free link: rdcu.be/ehkTV nature.com/articles/s4159…

I am thrilled to share that the first preprint from my lab is now available on bioRxiV! In this study, our team elucidates the role of autocrine ligands in the aberrant behavior of oncogene-driven lung cancer. biorxiv.org/content/10.110…

Mother's Day message going out to Dr. Mehmet Oz. Another mother's day for me, thnx to: LUNGevity Foundation Dr. Catharine Young GO2 for Lung Cancer LungCancerAmerica Drew Moghanaki Lung Cancer Research Foundation EGFR Resisters Narjust Florez, MD, FASCO Stephen V Liu, MD Jill Feldman ASCO American Cancer Society City of Hope Dr. Ravi Salgia Triparna Sen (Sen-Lab)

CAR-T Fellow post available UCLH. Application deadline 04/06/2025. Working with the fabulous Claire Roddie Maeve O'Reilly Paul Maciocia Mike Northend uclh.nhs.uk/work-with-us/c…

🔥New in Nature Genetics by Francisco Gimeno-Valiente during his postdoc at UCL under Nnennaya Kanu Charles Swanton 🔝 📌Genomic & epigenomic drivers converge in lung cancer. New methylation dN/dS + AllChAT reveal chromatin-driven dosage compensation. 🔗nature.com/articles/s4158…

Proud to share our first TRACERx cancer study integrating epigenomics + genomics in NSCLC as co-drivers of tumor evolution. Led by not me but by the wonderful Nnennaya Kanu, Francisco Gimeno-Valiente, Carla Castignani, Peter Van Loo

Read more from Charles Swanton about his latest work published in Cancer Discovery, in collaboration with Benjamin Werner, Mischel Lab, and colleagues 👇🏻

I am thrilled to have received a UKRI Future Leaders Fellowship! This award will enable my laboratory to uncover how our body's natural antiviral defences, including APOBEC3 enzymes, contribute to the earliest stages of lung cancer. ukri.org/news/ukri-anno…

Thank you very much!

Is air pollution keeping you awake at night? New international review from Johns Hopkins University University identifies #airpollution as a contributor to poor sleep. Piece by me. theguardian.com/environment/20…

The Division of Human Biology Fred Hutch Cancer Center is recruiting for a lab-based scientist at the Assistant or Associate Professor level. Come join a dynamic research community committed to pushing the boundaries of discovery in cancer biology. apply.interfolio.com/174007

Thank you very much!

We’re hiring a postdoc (≤2 yrs experience) with strong expertise in metabolism to study metabolic regulation of stroma–immune interactions in our lab MD Anderson Cancer Center. Only qualified applicants will be considered 👇lnkd.in/e_uajEFS

Are you interested in doing a #PhD in #cancerresearch? 🧪🧑‍🔬👨🏽‍🔬👩🏿‍🔬🧫🦠🔬 Do you want to develop new #biotherapeutics? Applications for our PhD programme are open! bit.ly/42kRdyJ #uclcancer #QMBCI #KCLcancer_pharm #KCL #TheCrick

Happy to announce the publication using advanced models to understand how T cells mediate efficient immunoediting in early sarcomas. This was a collaboration between Julie Cheung and Brian Hunt in the lab Thanks to Cancer Cell for publishing our work. cell.com/cancer-cell/fu…

We posted this preprint to bioRxiv Immunology that focuses on the idea that CD8 T cells can naturally survey and eliminate stem-cells in the colon epithelium that have neoantigens that are created by somatic mutation. This work was spearheaded by Jess Buck in the lab!